 Secondary objectives include: evaluating and describing the incidence of chemotherapy-induced peripheral neuropathy using the FACTGOG-Ntx assessment tool; evaluating the utility of adding ALCAR to the chemotherapy to reduce the incidence of peripheral neuropathy; and evaluating the utility of the Grooved Pegboard Completion Time as a longitudinal measure of peripheral neuropathy. 